Literature DB >> 185044

Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes.

M B Ranke, C A Stanley, A Tenore, D Rodbard, A M Bongiovanni, J S Parks.   

Abstract

Suspensions of rat hepatocytes isolated enzymatically by the method of Berry and Friend were used to study the binding of 125I-labeled human (hGH) and bovine (bGH) growth hormones and ovine prolactin (oPRL). Displacement of these labeled hormones by their unlabeled analogues was analyzed by means of Scatchard plots and affinity constants (K) and the number of binding sites per cell (q) were calculated. Specificity of binding was studied using hGH, bGH oPRL and rat growth hormone (rGH) and rat prolactin (rPRL). Rat hepatocytes contained two types of binding sites which bound hGH. The first, somatogenic, was specific for the growth-promoting hormones bGH and rGH. The second, lactogenic, was specific for lactogenic hormones, oPRL and rPRL. Human GH, which has both lactogenic and growth-promoting properties in rodents, bound to both sites. The somatogenic binding sites were present in both males and females, and the number of sites was similar in females and in males and was not affected by hypophysectomy. The lactogenic binding sites were present only in females, and the number of lactogenic and somatogenic sites was similar (40,000/cell). The affinity of hGH for the lactogenic binding sites was less than for the somatogenic (0.37 X 10(9) vs. 1 X 10(9)M-1). The lactogenic binding sites were lost when female rats were hypophysectomized and could not be restored by estrogen treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185044     DOI: 10.1210/endo-99-4-1033

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

Review 2.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

3.  Characterization of hepatic lactogen receptor. Subcellular distribution and characterization of N-linked carbohydrate chains.

Authors:  L A Haldosén; G Andersson; J A Gustafsson
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Heterogeneity of growth-hormone receptors detected with monoclonal antibodies to human growth hormone.

Authors:  H Thomas; I C Green; M Wallis; R Aston
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Formation of complexes between 125I-labelled human or bovine somatotropins and binding proteins in vivo in rat liver and kidney.

Authors:  J S Bonifacino; L P Roguin; A C Paladini
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

6.  Characterization of human somatotropin binding to detergent-solubilized lactogenic receptors from rat liver.

Authors:  J S Bonifacino; S H Sánchez; A C Paladini
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

7.  Characterization of prolactin binding by membrane preparations from rat liver.

Authors:  A M Silverstein; J F Richards
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

8.  Binding in vitro to rat liver receptors does not correlate with activities in vivo of bovine somatotropin. Use of chemically modified derivatives as probes.

Authors:  L P Roguin; J M Delfino; N Vita; A C Paladini
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

9.  Lactogenic and somatogenic binding sites in intact and detergent-solubilized membrane preparations of female rat liver.

Authors:  L A Haldosén; J A Gustafsson
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

10.  Bovine growth hormone induces oscillations in cytosolic free Ca2+ in single rat hepatocytes.

Authors:  I Marrero; A K Green; P H Cobbold; C J Dixon
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.